“It is said that pancreatic cancer is difficult to be detected in its early stages, and that lung cancer has the highest mortality rate among all cancers. With the launch of the EU-ME3, Olympus aims to enhance the standard of care including these diseases and to further improve the quality of life of patients.”
Hironobu Kawano, Head of Endoscopic Solutions Division at Olympus
Welcome to the Next Level of Endoscopic Ultrasound
Be the first to experience crystal-clear ultrasound images, multiple observation modes and functionalities.
Simply contact us.
The New Endoscopic Ultrasound Center at a Glance
Find all information on enhanced visualization and elastography, compatibilities, and technical specifications here.
Download EUS brochure Download EBUS brochurePress Release
Olympus EU-ME3 Ultrasound Processor Delivers Higher Resolution Images for Endoscopic Ultrasound
Olympus Corporation (Olympus), a global medtech company committed to making people’s lives healthier, safer and more fulfilling, today announced the launch of EU-ME3, a new Endoscopic Ultrasound Processor*, which addresses the needs of healthcare professionals for high-quality clear images when conducting the endoscopic ultrasound procedure. EU-ME3 will be launched in Europe, the Middle East, Africa, parts of Asia, and Oceania within this fiscal year. EU-ME3 has been exhibited during the 30th United European Gastroenterology Week (UEGWeek) from October 8 to 11, 2022.
Read more*This product may not yet be available in all countries. It can only be purchased in a specific country once all regulatory requirements of such country for making the product available on the market are met.